Javier Sanz

ORCID: 0000-0002-5501-8385
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cardiac Imaging and Diagnostics
  • Cardiovascular Function and Risk Factors
  • Advanced MRI Techniques and Applications
  • Pulmonary Hypertension Research and Treatments
  • Cerebrovascular and Carotid Artery Diseases
  • Cardiac Valve Diseases and Treatments
  • Cardiac Structural Anomalies and Repair
  • Cardiovascular Disease and Adiposity
  • Congenital Heart Disease Studies
  • Cardiomyopathy and Myosin Studies
  • Lipoproteins and Cardiovascular Health
  • Diabetes Treatment and Management
  • Coronary Interventions and Diagnostics
  • Cardiovascular Effects of Exercise
  • Cardiovascular Health and Disease Prevention
  • Advanced X-ray and CT Imaging
  • Infective Endocarditis Diagnosis and Management
  • Amyloidosis: Diagnosis, Treatment, Outcomes
  • Cardiac tumors and thrombi
  • Aortic Disease and Treatment Approaches
  • Coronary Artery Anomalies
  • Viral Infections and Immunology Research
  • Holomorphic and Operator Theory
  • Mechanical Circulatory Support Devices
  • Acute Myocardial Infarction Research

Cardiovascular Institute of the South
2013-2024

Icahn School of Medicine at Mount Sinai
2015-2024

Spanish National Centre for Cardiovascular Research
2014-2024

Mount Sinai Hospital
2008-2024

Mount Sinai Hospital
2009-2024

Mount Sinai Health System
2024

University of California, Irvine
2024

Hospital Del Mar
2023

Parc de Salut
2016-2023

Universitat Pompeu Fabra
2016-2023

Absence of cardiovascular risk factors (CVRFs) is traditionally considered low for atherosclerosis; however, individuals without CVRFs, as currently defined, still have events.This study sought to identify predictors subclinical atherosclerosis in CVRF-free individuals.Participants from the PESA (Progression Early Subclinical Atherosclerosis) (n = 4,184) conventional CVRFs were evaluated 1,779; 45.0 ± 4.1 years, 50.3% women). CVRF freedom was defined no current smoking and untreated blood...

10.1016/j.jacc.2017.10.024 article EN cc-by-nc-nd Journal of the American College of Cardiology 2017-12-01

<h3>Objective</h3> To quantify right ventriculo-arterial coupling in pulmonary hypertension by combining standard heart catheterisation (RHC) and cardiac magnetic resonance (CMR) to estimate it non-invasively with CMR alone. <h3>Design</h3> Cross-sectional analysis a retrospective cohort of consecutive patients. <h3>Setting</h3> Tertiary care centre. <h3>Patients</h3> 139 adults referred for evaluation. <h3>Interventions</h3> RHC within 2 days (n=151 test pairs). <h3>Main outcome...

10.1136/heartjnl-2011-300462 article EN Heart 2011-09-13

Even when low-density lipoprotein-cholesterol (LDL-C) levels are lower than guideline thresholds, a residual risk of atherosclerosis remains. It is unknown whether triglyceride (TG) associated with subclinical and vascular inflammation regardless LDL-C. This study sought to assess the association between serum TG early in apparently healthy individuals. An observational, longitudinal, prospective cohort study, including 3,754 middle-aged individuals low moderate cardiovascular from PESA...

10.1016/j.jacc.2021.04.059 article EN cc-by-nc-nd Journal of the American College of Cardiology 2021-06-01

It is assumed that the survival factors Bcl-2 and Bcl-xL are mainly functional on mitochondria therefore must contain mitochondrial targeting sequences. Here we show, however, only specifically targeted to outer membrane (MOM) whereas distributes several intracellular membranes. Mitochondrial of requires COOH-terminal transmembrane (TM) domain flanked at both ends by least two basic amino acids. This sequence a bona fide signal for MOM as it confers specific localization soluble EGFP. The...

10.1083/jcb.200210084 article EN The Journal of Cell Biology 2003-01-06

To retrospectively identify pulmonary arterial (PA) flow parameters measured with phase-contrast magnetic resonance (MR) imaging that allow noninvasive diagnosis of chronic PA hypertension (PAH).The study was HIPAA compliant and approved by the institutional review board; a waiver informed consent obtained. Fifty-nine patients (49 female patients; mean age, 46 years; range, 16-85 years) known to have or suspected having PAH underwent breath-hold MR right-sided heart catheterization (RHC)....

10.1148/radiol.2431060477 article EN Radiology 2007-03-01

Beta-blockers improve clinical outcome when administered early after acute myocardial infarction. However, whether beta-blockers actually reduce the infarction size is still in dispute. Cardiac magnetic resonance imaging can accurately depict left ventricular (LV) ischemic myocardium at risk (T2-weighted hyperintense region) infarction, as well extent of necrosis (delayed gadolinium enhancement). The aim this study was to determine administration metoprolol could increase salvage, measured...

10.1161/circulationaha.106.679639 article EN Circulation 2007-05-22

Fingolimod, a sphingosine-1-phosphate receptor agonist, is used for the treatment of multiple sclerosis and exerts antiapoptotic properties. We hypothesized that activation with fingolimod during acute myocardial infarction (MI) inhibits apoptosis, leading to increased salvage, reduced infarct size, mitigated left ventricular (LV) remodeling in porcine model ischemia/reperfusion.Ischemia/reperfusion was induced pigs by balloon occlusion anterior descending artery, followed reperfusion....

10.1161/circulationaha.115.012427 article EN Circulation 2016-01-30
Coming Soon ...